• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区一名男童因甲状腺激素受体β 第 349 位缬氨酸突变为丙氨酸(THRB p.Val349Ala)而导致的甲状腺激素抵抗。

Resistance to thyroid hormone due to a novel THRB p.Val349Ala mutation in a Taiwanese boy.

机构信息

Department of Pediatrics, National Taiwan University Hospital and National, Taiwan University College of Medicine, Taipei, 100, Taiwan.

Department of Pediatrics, National Taiwan University Hospital and National, Taiwan University College of Medicine, Taipei, 100, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, 100, Taiwan.

出版信息

J Formos Med Assoc. 2020 Oct;119(10):1546-1549. doi: 10.1016/j.jfma.2020.05.035. Epub 2020 Jun 3.

DOI:10.1016/j.jfma.2020.05.035
PMID:32505587
Abstract

Resistance to thyroid hormone (RTH) is a rare congenital disorder characterized by impaired sensitivity of target tissues to thyroid hormone. The disease is mostly caused by heterozygous mutations of thyroid hormone receptor β (THRB) gene. We present a ten-year-old Taiwanese boy with goiter, mood disturbances and attention deficit hyperactivity disorder (ADHD). Blood tests showed elevated serum thyroxine (T4) and triiodothyronine (T3) levels with nonsuppressed thyrotropin (TSH) levels. Sella MRI failed to detect any pituitary adenoma. Initial treatment with anti-thyroid drugs resulted in increased TSH levels and goiter size. His medication was discontinued after his visit to our hospital for a second opinion. A thyrotropin-releasing hormone (TRH) stimulation test showed a normal TSH response to TRH stimulation. Molecular analysis identified a novel heterozygous THRB p.Val349Ala mutation. The patient attained normal growth and a paucity of symptoms without any medication during the follow-up period. We hope that the presentation of this case can make the early diagnosis of RTH possible so that inappropriate management of these patients can be avoided in the future.

摘要

抗甲状腺激素(RTH)是一种罕见的先天性疾病,其特征是靶组织对甲状腺激素的敏感性降低。该病主要由甲状腺激素受体β(THRB)基因突变引起。我们报告了一例 10 岁台湾男孩,其表现为甲状腺肿、情绪障碍和注意缺陷多动障碍(ADHD)。血液检查显示血清甲状腺素(T4)和三碘甲状腺原氨酸(T3)水平升高,促甲状腺素(TSH)水平未受抑制。鞍区 MRI 未能发现垂体腺瘤。最初使用抗甲状腺药物治疗导致 TSH 水平升高和甲状腺肿增大。在我院就诊后,他停止了药物治疗。促甲状腺激素释放激素(TRH)刺激试验显示 TSH 对 TRH 刺激的正常反应。分子分析发现了一种新的 THRB p.Val349Ala 突变杂合子。在随访期间,该患者无需任何药物治疗,生长正常,症状减轻。我们希望本病例的介绍可以实现 RTH 的早期诊断,从而避免未来对这些患者的不当管理。

相似文献

1
Resistance to thyroid hormone due to a novel THRB p.Val349Ala mutation in a Taiwanese boy.台湾地区一名男童因甲状腺激素受体β 第 349 位缬氨酸突变为丙氨酸(THRB p.Val349Ala)而导致的甲状腺激素抵抗。
J Formos Med Assoc. 2020 Oct;119(10):1546-1549. doi: 10.1016/j.jfma.2020.05.035. Epub 2020 Jun 3.
2
Assessing the clinical and molecular diagnosis of inherited forms of impaired sensitivity to thyroid hormone from a single tertiary center.评估单中心遗传性甲状腺激素不敏感综合征的临床及分子诊断。
Endocrine. 2018 Dec;62(3):628-638. doi: 10.1007/s12020-018-1673-6. Epub 2018 Jul 19.
3
Diagnosis of Resistance to Thyroid Hormone due to a Rare Mutation in the Thyroid Hormone Receptor Beta Gene in a Patient Previously Presumed to Have Graves' Disease.诊断因甲状腺激素受体β基因罕见突变导致的甲状腺激素抵抗,该患者先前被误诊为格雷夫斯病。
Mil Med. 2024 Jan 23;189(1-2):e439-e442. doi: 10.1093/milmed/usad283.
4
Thyroid hormone resistance from newborns to adults: a Spanish experience.从新生儿到成人的甲状腺激素抵抗:西班牙的经验。
J Endocrinol Invest. 2019 Aug;42(8):941-949. doi: 10.1007/s40618-019-1007-4. Epub 2019 Feb 1.
5
Apparent resistance to thyroid hormones: From biological interference to genetics.甲状腺激素抵抗的表观遗传学机制:从生物学干扰到基因。
Ann Endocrinol (Paris). 2019 Nov;80(5-6):280-285. doi: 10.1016/j.ando.2019.06.005. Epub 2019 Jul 26.
6
Two Novel Mutations in the Thyroid Hormone Receptor β in Patients with Resistance to Thyroid Hormone (RTH β): Clinical, Biochemical, and Molecular Data.甲状腺激素抵抗(RTHβ)患者甲状腺激素受体β的两种新型突变:临床、生化和分子数据
Horm Metab Res. 2015 Nov;47(12):889-94. doi: 10.1055/s-0035-1545305. Epub 2015 Mar 4.
7
Challenging diagnosis of resistance to thyroid hormone in a patient with pituitary adenoma.垂体腺瘤患者甲状腺激素抵抗的诊断难题
BMJ Case Rep. 2019 Jul 19;12(7):e229430. doi: 10.1136/bcr-2019-229430.
8
A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma.一名甲状腺激素抵抗患者的垂体瘤:诊断难题。
Thyroid. 2001 Mar;11(3):281-91. doi: 10.1089/105072501750159750.
9
Variable Clinical Characteristics and Molecular Spectrum of Patients with Syndromes of Reduced Sensitivity to Thyroid Hormone: Genetic Defects in the THRB and SLC16A2 Genes.对甲状腺激素反应低下综合征患者的临床特征和分子谱的可变分析:THRB 和 SLC16A2 基因的遗传缺陷。
Horm Res Paediatr. 2018;90(5):283-290. doi: 10.1159/000493468. Epub 2018 Nov 29.
10
Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report.采用新型THRB突变治疗严重甲状腺激素β抵抗的隔日左甲状腺素钠成功疗法;病例报告
BMC Endocr Disord. 2016 Jan 12;16:1. doi: 10.1186/s12902-015-0081-7.

引用本文的文献

1
Reduced pituitary size in subjects with mutations in the THRB gene and thyroid hormone resistance.THRB基因发生突变且存在甲状腺激素抵抗的受试者垂体体积减小。
Endocr Connect. 2022 Jan 19;11(1):e210473. doi: 10.1530/EC-21-0473.